Rajesh Jain has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rajesh Jain, a promoter / person in control of Panacea Biotec, has submitted a disclosure to the stock exchange under Regulation 10(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Regulation 10(5) deals specifically with reporting of encumbrance (pledge) on shares — i.e., creation of a new pledge, invocation of an existing pledge, or release of a pledge. The headline does not state which of these events has occurred, nor does it disclose the number of shares or the percentage of holding involved. Shareholders would need to view the actual disclosure form on the BSE/NSE website to know the exact nature and size of the transaction.
Pledge-related disclosures can move the stock — pledges being created or invoked often signal financial stress, while releases are seen as positive. Without the details of this filing, investors should check the full disclosure before drawing any conclusions about the promoter's financial position or potential overhang on the stock.